A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma
SymBio Pharmaceuticals
SymBio Pharmaceuticals
Bristol-Myers Squibb
Chongqing Precision Biotech Co., Ltd
Daiichi Sankyo
Actuate Therapeutics Inc.
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
miRagen Therapeutics, Inc.
MP Biomedicals, LLC
Celgene
MP Biomedicals, LLC
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Novartis
Kyowa Kirin Co., Ltd.
MP Biomedicals, LLC